Professional Documents
Culture Documents
BSN 3D
Systemic Lupus Erythematous
Predisposing Factors: Precipitating Factors:
Age Environmental
Gender UNKNOWN Drug-Induced
Hereditary ETIOLOGY Infection
Race
Hormonal
Female producing estrogen First generation familial possession of Infectious agent’s n the body
influencing SLE DNA
Spontaneous
occurrence of SLE
activation.
Defective B-cell
Impaired membrane integrity of dendritic Presented to T-cells activation by
cells autoantigens
Various
Autoantibody Autoreactive cytotoxic T-cell activation Negative abnormal B-
productions cell contribution to
already deficient
immune system.
Inflammation of the affected system
SYSTEMIC LUPUS
Production of Anti-Nuclear
ERYTHEMATOUS
Antibodies (ANA) in renal (SLE)
cells
Lymphopenia
Thrombocytopenia Platelet destruction
and reduction Cellular
membrane
component
damage
Platelet aggregation
and clot formation
Serositis
Elevated intracranial pressure
Diagnostic Test Categories of Treatment Management
ANA (antinuclear Recognize flare-ups
antibody)titer o Conservative Schedule rest & activity
Maintain integrity of
Inc. ESR and C o Aggressive immune system
reactive protein Lessen stress
o Avoid environmental
Decrease C3 and triggers
C4 Stop drugs that induces
attacks
CBC Plasmapheresis
Induced reflux of
Nausea and
gastric acid
Vomiting
Acute Glomerulonephritis
Etiology
Formation of antibody
Inflammatory response
Kidney biopsy
Urinalysis: presence
of RBC, WBC, mixed call
casts & protein.
Edema
Hypertension
↓ urinary output
Urine dark in color
Anorexia
Irritability lethargy ACUTE
Oliguria
Hematuria GLOMERULO-
Proteinuria NEPHRITIS
Bibasilar crackles